Comprehensive Evidence Review: Persistent Macrocytic Anemia and Suspected MDS
BioSyntex Laboratories conducted a comprehensive review of current hematology guidelines, peer-reviewed literature, and clinical evidence regarding the evaluation and management of persistent macrocytic anemia in an elderly patient with suspected myelodysplastic syndrome (MDS).
The 73-page evidence review examines reversible causes of macrocytosis and cytopenias, vitamin B12 and other nutritional deficiencies, bone marrow evaluation, cytogenetic and molecular testing, Retacrit (epoetin alfa) safety and monitoring, and evidence-based strategies for diagnostic evaluation and ongoing clinical assessment.
Read the full 73-page BioSyntex Laboratories evidence review:
A Comprehensive Review of Current Guidelines, Evidence, and Clinical Implications
Additional Research: When Serum Vitamin B12 May Not Tell the Full Story
This additional review examines evidence that clinically significant vitamin B12 deficiency may occur despite normal or borderline serum B12 levels. It addresses situations in which conventional serum B12 testing may not fully reflect functional B12 status and reviews how vitamin B12 deficiency may produce megaloblastic or dysplastic hematologic findings that can overlap with findings seen in myelodysplastic syndromes.
The report examines MMA, homocysteine, holotranscobalamin, pernicious-anemia testing, and multi-marker diagnostic strategies when serum B12 results are discordant with the clinical or hematologic picture.
Read the full BioSyntex Laboratories research report:
Supporting Research Reports: Laboratory Evaluation and Treatment Monitoring
The following BioSyntex Laboratories research reports provide additional evidence and clinical context for laboratory evaluation, interpretation of abnormal findings, and monitoring of expected laboratory changes during treatment. Each report includes direct links to underlying scientific and clinical sources where applicable.
1. Laboratory Reference Ranges and Clinical Interpretation
This report reviews authoritative reference ranges and the clinical interpretation of laboratory tests relevant to the evaluation of significant macrocytic anemia in an elderly adult.
2. Clinician-Directed Next Steps and Treatment Considerations
This report examines what abnormal laboratory findings may indicate, typical clinician-directed next steps for further evaluation, and potential treatment considerations in adults being evaluated for macrocytic anemia. Diagnostic evaluation and treatment considerations are presented separately, with direct links to supporting literature.
3. Expected Laboratory Changes After B12/Folate and Retacrit Treatment
This report reviews the expected direction and typical timing of laboratory changes following vitamin B12/folate repletion and treatment with epoetin alfa (Retacrit), including reticulocyte response, hemoglobin and RBC trends, MCV, functional vitamin markers, and other laboratory parameters used to assess treatment response.
Clinical Research Note: These materials are provided as evidence reviews and research resources for clinician consideration. They are not intended to replace individualized medical evaluation, diagnosis, or treatment decisions by the patient’s treating healthcare professionals.
